Merck

Earnings Preview: Merck & Co.
Yahoo/AP
Wed, 07/25/12 - 09:25 am
Merck
earnings
Investing in the Companies that will Beat HIV
Motley Fool
Wed, 07/25/12 - 09:22 am
HIV
Gilead
JNJ
Merck
Bristol-Myers Squibb
Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV
Yahoo
Tue, 07/24/12 - 09:19 am
MK-1439
Merck
HIV
Yamasa
Chimerix
CMX157
EFdA
What Does Wall Street See for Merck's Q2?
Motley Fool
Mon, 07/23/12 - 10:09 pm
Merck
earnings
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Merck: Experts In Patent Cliff Management
Motley Fool
Fri, 07/20/12 - 10:31 am
patents
Merck
patent cliff
Merck: New Sleeping Pill Thwarts Brain’s Up-All-Night Neurons
Bloomberg
Fri, 07/20/12 - 09:33 am
Merck
insomnia
orexin receptors
GSK
Takeda
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Fri, 07/20/12 - 09:30 am
Merck
Abbott Labs
Amgen
GSK
Pfizer
Eli Lilly
osteoporosis
Odanacatib
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
Merck stock hits new 52-week high
TheStreet.com
Tue, 07/17/12 - 12:28 pm
Merck
Schering-Plough’s K-Dur Pay-For-Delay Ruling Reversed
Bloomberg
Mon, 07/16/12 - 07:32 pm
Schering Plough
pay-for-delay
K-Dur
Merck
Sanofi: Don't Ignore This Powerhouse
Seeking Alpha
Mon, 07/16/12 - 08:47 am
Sanofi
Merck
Pfizer
Bristol-Myers Squibb
Bayer
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
GSK
Amylin
AstraZeneca
Merck
Novartis
Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Fri, 07/13/12 - 01:22 pm
Merck
Novartis
Pfizer
AstraZeneca
Alzheimer's Drug Research at Make or Break Juncture
Forbes
Fri, 07/13/12 - 12:45 pm
Alzheimer's disease
Merck
Pfizer
Eli Lilly
JNJ
Can These 3 Companies Take Down Gilead?
Motley Fool
Thu, 07/12/12 - 11:27 am
Gilead
HIV
ViiV Healthcare
Shionogi
Merck
Bristol-Myers Squibb
Merck Hits 4-Year High As Osteoporosis Drug Shines
Investors.com
Thu, 07/12/12 - 11:23 am
Merck
osteoporosis
Odanacatib
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
The Butterfly Effect Of The Affordable Care Act
Seeking Alpha
Wed, 07/11/12 - 12:05 pm
Affordable Care Act
healthcare reform
Abbott Laboratories
Merck
Pfizer
Unitedhealth Group
Wellpoint
Merck Hid Evidence Of Vioxx Harm: Study
Pharmalot
Tue, 07/10/12 - 12:11 pm
Vioxx
Merck

Pages